Antihypertensive effect of Iranian Crataegus curvisepala Lind.: A randomized, double-blind study

Drugs under Experimental and Clinical Research

Volumn 30, Issue 5-6, 2004, Pages 221-225

  Asgary, S ^a   Naderi, G H ^a   Sadeghi, M ^a   Kelishadi, R ^a   Amiri, M ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHREKORD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CRATAEGUS EXTRACT; PLACEBO;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; IRAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ADULT; ANTIHYPERTENSIVE AGENTS; CRATAEGUS; DOUBLE-BLIND METHOD; FEMALE; FLOWERS; HUMANS; HYPERTENSION; IRAN; MALE; MIDDLE AGED; PLANT EXTRACTS; PLANT LEAVES;

EID: 11444267569     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Reynolds J.E.F. (Ed.). "Martindale. The Extra Pharmacopeia. 29th Edition." The Pharmaceutical Press, London, 1989, pp. 823-824.
2. Zargary A. "Medicinal Plant. Vol. 2, 4th Edition." Tehran University Publications, Tehran, 1986, pp. 263-4.
3. Tyler V.E., Brady L.R., Robbert J.G. "Pharmacognosy. 9th Edition." Lea and Febiger, Philadelphia, 1988, p. 476.
4. Schuessler M., Hoelzl J., Fricke U. Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung, 45, 842, 1995.
5. Krzeminski T., Chatterjee S. Ischemia and early reperfusion induced arrythmias: Benefical effects of an extract of Crataegus oxyacantha. Pharm. Pharmacol., 3, 45, 1995.
6. Ghassemi N., Ghannadi A., Mohtaj F. Morphological and phytochemical investigations on Crataegus curvisepala and Crataegus oxyacantha. Daru (Journal of the School of Pharmacy, Tehran University of Medical Sciences), 6(1, 2), 25, 1996.
7. Leung A.Y., Foster S. "Encyclopedia of Common Natural Ingredients used in Food, Drugs and Cosmetics. 2nd Edition." John Wiley & Sons, Inc., New York, 1996, pp. 259-297.
8. Asgary S., Sarafzadegan N., Naderi G., Ghannadi A. Antihyperlipidemic effects of Crataegus curvisepala Lind. Intercontinental Cardiology, 7(2), 73, 1998.
9. Rigelsky J.M., Sweet B.W. Hawthorn: Pharmacology and therapeutic uses. Am. J. Health Syst. Pharm., 59(2), 417, 2002.
10. List P.H., Schmidt P. Technologie Pflanzlieher Arzneizubereiturgen Wissenschaftliche Verlagsgesellschaft GmbH, Stuttgart, 1982, pp. 263-265.
11. Ghassemi N., Ghannadi A.R. A study on the morphology and phytochemistry of some Iranian Equisetum species. Planta Med., 59(Suppl.), 63, 1983.
12. Wichtl M. "Die Pharmakognostiche Chemische Analyse." Akademische Verlagsgesellschaft, Frankfurt, 1971, p. 185.
13. Rose G.A., Blackburn H. "Cardiovascular survey methods." WHO, Geneva, 1982.
14. Keys A. "Seven Countries." Harvard University Press, Cambridge, MA, 1980.
15. Kannel W.B., Wolf P.A., Garrison R.J. The Framingham Study: An Epidemiological Iinvestigation of Cardiovascular Disease. Section 37: The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. Springfield, National Technical Information Service, 1987.
16. Johannesson M., Borgquist L., Jonsson B., Rostam L. The costs of treating hypertension in Sweden: An empirical investigation in primary health care. Scand. J. Prim. Health Care, 9, 155, 1991.
17. MacMahon S., Peto R., Culter J., et al. Blood pressure, stroke, and coronary heart disease. Part 1: Prolonged differences in blood pressure: Prospective observational studies corrected for regression dilution bias. Lancet, 335, 765, 1990.
18. MacMahon S. Blood pressure and the prevention of stroke. J. Hypertens., 14(Suppl. 6), 536, 1996.
19. Wagner, H. "Pharmazeutische Biologie. 2: Drogen und ihre inhaltsstofe. 4 Auflage." Gustav Fischer Verlag, Stuttgart, 1988, pp. 245-250.
20. Leukel A., Fricke U., Holzl J. Studies on the activity of Crataegus compounds upon the isolated guinea pig heart. Planta Med., 52, 545, 1986.